AL
SCHW

Aspiriant LLC’s Charles Schwab SCHW Stock Holding History

Aspiriant LLC’s Portfolio SCHW Stock Details SCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.23M Sell
23,700
-545
-2% -$53.5K 0.06% 100
2025
Q4 		$2.42M Buy
24,245
+432
+2% +$41K 0.07% 96
2025
Q3 		$2.27M Sell
23,813
-993
-4% -$94.3K 0.07% 93
2025
Q2 		$2.26M Sell
24,806
-1,126
-4% -$94.3K 0.07% 94
2025
Q1 		$2.03M Buy
25,932
+192
+0.7% +$15.1K 0.07% 94
2024
Q4 		$1.91M Buy
25,740
+422
+2% +$31.6K 0.07% 97
2024
Q3 		$1.64M Sell
25,318
-500
-2% -$32.8K 0.06% 107
2024
Q2 		$1.9M Sell
25,818
-568
-2% -$42K 0.08% 94
2024
Q1 		$1.91M Sell
26,386
-156
-0.6% -$10.3K 0.08% 97
2023
Q4 		$1.83M Buy
26,542
+537
+2% +$31K 0.08% 96
2023
Q3 		$1.43M Buy
26,005
+294
+1% +$17.8K 0.07% 107
2023
Q2 		$1.46M Sell
25,711
-290
-1% -$15.2K 0.07% 103
2023
Q1 		$1.36M Buy
26,001
+115
+0.4% +$8.42K 0.07% 108
2022
Q4 		$2.16M Buy
25,886
+305
+1% +$23.7K 0.11% 85
2022
Q3 		$1.84M Sell
25,581
-986
-4% -$68.5K 0.09% 88
2022
Q2 		$1.68M Buy
26,567
+704
+3% +$48.6K 0.08% 90
2022
Q1 		$2.18M Buy
25,863
+348
+1% +$30.6K 0.12% 83
2021
Q4 		$2.14M Buy
25,515
+876
+4% +$70.9K 0.11% 86
2021
Q3 		$1.8M Sell
24,639
-3
-0% -$214 0.11% 81
2021
Q2 		$1.79M Buy
24,642
+352
+1% +$24.9K 0.1% 79
2021
Q1 		$1.58M Sell
24,290
-993
-4% -$60.2K 0.1% 75
2020
Q4 		$1.34M Sell
25,283
-425
-2% -$19.2K 0.09% 82
2020
Q3 		$930K Sell
25,708
-2,425
-9% -$84.4K 0.07% 101
2020
Q2 		$952K Sell
28,133
-4,267
-13% -$153K 0.09% 85
2020
Q1 		$1.09M Sell
32,400
-4,949
-13% -$208K 0.11% 75
2019
Q4 		$1.78M Sell
37,349
-1,417
-4% -$62.5K 0.16% 61
2019
Q3 		$1.63M Sell
38,766
-3,235
-8% -$131K 0.15% 79
2019
Q2 		$1.69M Sell
42,001
-4,308
-9% -$188K 0.14% 84
2019
Q1 		$1.98M Sell
46,309
-2,683
-5% -$121K 0.16% 81
2018
Q4 		$2.03M Sell
48,992
-1,953
-4% -$88.3K 0.15% 80
2018
Q3 		$2.49M Sell
50,945
-3,118
-6% -$159K 0.21% 72
2018
Q2 		$2.76M Sell
54,063
-1,982
-4% -$110K 0.24% 66
2018
Q1 		$2.93M Buy
56,045
+50,553
+920% +$2.71M 0.26% 58
2017
Q4 		$282K Sell
5,492
-49,267
-90% -$2.31M 0.08% 67
2017
Q3 		$2.4M Sell
54,759
-8,324
-13% -$346K 0.2% 67
2017
Q2 		$2.71M Sell
63,083
-7,569
-11% -$303K 0.24% 64
2017
Q1 		$2.88M Sell
70,652
-3,828
-5% -$158K 0.25% 66
2016
Q4 		$2.94M Sell
74,480
-1,640
-2% -$58.6K 0.27% 53
2016
Q3 		$2.4M Sell
76,120
-27,537
-27% -$807K 0.24% 62
2016
Q2 		$3.38M Buy
103,657
+21,102
+26% +$600K 0.32% 55
2016
Q1 		$2.31M Buy
+82,555
New +$2.18M 0.22% 65

Other funds holding SCHW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Aspiriant LLC's SCHW Position: Q1 2026 in Review

Aspiriant LLC reduced its Charles Schwab (SCHW) stake by 2.2% in Q1 2026, selling an estimated $53.5K and leaving 23,700 shares worth $2.23M. The position accounts for 0.06% of the portfolio, ranked #100.

Aspiriant LLC first reported a position in SCHW in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.38M in Q2 2016. 2,319 funds tracked by Wall St. Rank hold SCHW as of Q1 2026.

  • Aspiriant LLC held 23,700 shares of Charles Schwab worth $2.23M as of Q1 2026.
  • Aspiriant LLC sold 545 Charles Schwab shares in Q1 2026, an estimated $53.5K.
  • Charles Schwab made up 0.06% of Aspiriant LLC's portfolio in Q1 2026, its #100 holding.
  • Aspiriant LLC first reported a position in Charles Schwab in Q1 2016 and has held it in 41 quarters since.
  • Aspiriant LLC's Charles Schwab position peaked at $3.38M in Q2 2016.
  • 2,319 funds tracked by Wall St. Rank held Charles Schwab as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.